financetom
Business
financetom
/
Business
/
US tariff doubling cut EU steel exports by 34%, steel body says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US tariff doubling cut EU steel exports by 34%, steel body says
Jun 3, 2026 3:25 PM

BRUSSELS, June 4 (Reuters) - EU steel exports to the U.S. have fallen by 34% since Washington hiked tariffs to 50%, with higher duties on derivative products such as washing machines and motorbikes also hitting European demand, steel industry association Eurofer said on Thursday. 

Steel exports to the U.S. fell to 1.94 million metric tons in the three quarters since the Trump administration doubled import tariffs on steel and aluminium from 25% a year ago.

European Union producers exported 3.4 million tons to the United States in 2025, compared with 4.1 million tons in 2024 and 4.7 million tons in 2017, Eurofer said.

Eurofer said it was important the EU and the U.S. carried out their trade deal struck last July in full. 

That agreement, struck at President Donald Trump's Turnberry golf course in Scotland, sets out that the EU should remove its duties on most U.S. goods imports in return for a broad 15% U.S. tariff on EU exports.

It also said the two sides should discuss possible tariff-free steel and aluminium quotas and cooperation to address global overcapacity.

Axel Eggert, Eurofer director general, said the U.S. needs to fulfil its commitment to work with the EU to find a solution.

A further problem EU producers have faced are U.S. tariffs on 'derivative' products, for which the metal content was initially subject to a 50% tariff. Trump even widened the range of products a month after the Turnberry deal.

Trump's administration has since lowered a number of tariff rates, with a proclamation on Monday reducing the rate on some products to 15% for the EU. Still, for fridges, lawn mowers or rail parts, the rate is 25%. 

The EU could suspend some concessions if this does not fall to 15% by the end of the year.  

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
T-Mobile US Fined $60 Million for Data Breach
T-Mobile US Fined $60 Million for Data Breach
Aug 15, 2024
07:39 AM EDT, 08/15/2024 (MT Newswires) -- T-Mobile US ( TMUS ) was fined $60 million for data breach incidents and failing to promptly report these, violating the national security agreement that allowed its merger with Sprint to push through, the Committee on Foreign Investment in the US said. CFIUS said T-Mobile failed to prevent unauthorized access to certain sensitive...
Alaska Air, Hawaiian further extend review period of proposed deal
Alaska Air, Hawaiian further extend review period of proposed deal
Aug 15, 2024
(Reuters) - Alaska Air ( ALK ) said on Thursday it has agreed to further extend the review period of its proposed $1.9 billion acquisition of peer Hawaiian Holdings ( HA ) with the U.S. Department of Justice (DOJ). The companies will extend the review period with the DOJ until 12:01 AM ET, Aug 20. On Wednesday, the airlines had...
Cellebrite's Q2 Adjusted Earnings, Revenue Increase; 2024 Outlook Raised
Cellebrite's Q2 Adjusted Earnings, Revenue Increase; 2024 Outlook Raised
Aug 15, 2024
07:41 AM EDT, 08/15/2024 (MT Newswires) -- Cellebrite DI ( CLBT ) reported Q2 adjusted earnings Thursday of $0.10 per diluted share, up from $0.05 a year earlier. Analysts surveyed by Capital IQ expected $0.05. Revenue for the quarter ended June 30 was $95.7 million, compared with $76.7 million a year earlier. Analysts polled by Capital IQ expected $91.9 million....
KalVista Secures EMA Validation of Marketing Authorization Application for Hereditary Angioedema Treatment
KalVista Secures EMA Validation of Marketing Authorization Application for Hereditary Angioedema Treatment
Aug 15, 2024
07:42 AM EDT, 08/15/2024 (MT Newswires) -- KalVista Pharmaceuticals ( KALV ) said Thursday that the European Medicines Agency has validated its marketing authorization application for sebetralstat, an oral plasma kallikrein inhibitor designed for the on-demand treatment of hereditary angioedema. The application, submitted in July, will next undergo review by the EMA's Committee for Medicinal Products for Human Use through...
Copyright 2023-2026 - www.financetom.com All Rights Reserved